COLLPLANT BIOTECH. IS-,01
COLLPLANT BIOTECH. IS-,01
Certificado de depósito · IL0004960188 · CLGN · A1CY27 (XTAE)
Resumen
1,71 EUR
-3,23 % -0,06 EUR
Frankfurt (XNAS) · Precios actuales y gráficos en MoneyPeak
06.06.2025 19:59

Cotizaciones actuales de COLLPLANT BIOTECH. IS-,01

BolsaTickerMonedaÚltima operaciónPrecioVariación diaria
XNAS: NASDAQ
NASDAQ
CLGN
USD
06.06.2025 19:59
1,95 USD
2,04 USD
-4,66 %

Rendimiento

Día Semana Mes 3 meses 6 meses 1 año 5 años
0,00 % -38,44 % 0,0023 % -39,58 % -54,92 % -65,21 % -81,43 %

Perfil de la empresa para COLLPLANT BIOTECH. IS-,01 Certificado de depósito

CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, and Europe. Its products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering technology. The company's products include BioInks for 3D printing of tissues and organs; dermal filler and soft tissue fillers for treating wrinkles; 3D Bioprinted breast implants for regeneration of breast tissue; injectable implants to promote breast tissue regeneration; 3D bioprinted regenerative soft tissue matrix; VergenixSTR, a soft tissue repair matrix intended for the treatment of tendinopathy; and VergenixFG, an advanced wound care product for the treatment of deep surgical incisions and wounds, including diabetic ulcers, venous and pressure ulcers, burns, bedsores, and other chronic wounds. It has collaboration agreements with 3D Systems Corporation; CellInk, a BICO Group company; Advanced Regenerative Manufacturing Institute; RegenMed Development Organization; Israel's Technion Institute of Technology; AbbVie; and STEMCELL. The company was formerly known as CollPlant Holdings Ltd. and changed its name to CollPlant Biotechnologies Ltd. in June 2019. CollPlant Biotechnologies Ltd. was founded in 2004 and is headquartered in Rehovot, Israel.

Datos de la empresa

Nombre COLLPLANT BIOTECH. IS-,01
Empresa CollPlant Biotechnologies Ltd.
Símbolo CLGN
Sitio web https://www.collplant.com
Mercado principal XTAE Frankfurt
WKN A1CY27
ISIN IL0004960188
Tipo de valor Certificado de depósito
Sector Healthcare
Industria Biotechnology
CEO Mr. Yehiel Tal
Capitalización de mercado 28 Mio
País Israel
Moneda EUR
Empleados 0,1 T
Dirección Weizmann Science Park, 7670104 Rehovot
Fecha de OPV 2018-01-31

Cambios de identificador

Fecha De A
05.02.2018 CQPTY CLGN

Símbolos de cotización

Nombre Símbolo
Frankfurt CPT.F
NASDAQ CLGN

Otras acciones

Los inversores que tienen COLLPLANT BIOTECH. IS-,01 también tienen las siguientes acciones en su cartera:
Cohen & Steers Real Estate Opportunities and Income Fund Common Shares of Beneficial Interest
Cohen & Steers Real Estate Opportunities and Income Fund Common Shares of Beneficial Interest Fondo
SG ISSUER NTS 08/12/23
SG ISSUER NTS 08/12/23 Bono
La plataforma financiera MoneyPeak rastrea y analiza inversiones y carteras. Desde depósitos de valores hasta compras de criptomonedas.
Útil, simple y gratuito. Acciones, ETF, ETC, ETN, índices, fondos, bonos, certificados, divisas, opciones, derechos de suscripción.
Aviso legal Protección de datos Blog Comunidad Comentarios Changelog
Im App Store herunterladen Bei Google Play herunterladen
Todos los derechos reservados © LCP GmbH 2025